Mexico
Every company in the roster headquartered in Mexico.
Every company in the roster headquartered in Mexico.
4 of 4 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Laboratorios SanferPrivate | 1 asset: 1 Ph 3 | efpeglenatidePhase 3 · ObesityReliable signal | Nov 2027efpeglenatide · Phase 3 | — | — | — | — |
M8 PharmaceuticalsPrivate | 1 asset: 1 approved | Approved assets only | Dec 2026viloxazine · Phase 3 | — | — | — | — |
MedixPrivate | 1 asset: 1 Ph 3 | TesofensinePhase 3 · ObesityReliable signal | None on record | — | — | — | — |
StendhalPrivate | 1 asset: 1 Ph 3 | GemigliptinPhase 3 · Type 2 DiabetesReliable signal | None on record | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.